Paper41665249
The Metabolic State of E. coli Influences Fosfomycin Efficacy and Promotes Resistance Evolution.
Verhülsdonk A and 5 others. ACS Infect Dis, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. The Metabolic State of E. coli Influences Fosfomycin Efficacy and Promotes Resistance Evolution. Papers, record 41665249. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41665249
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Metabolic State of E. coli Influences Fosfomycin Efficacy and Promotes Resistance Evolution.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fosfomycin | Major topic |
| Escherichia coli | Major topic |
| Anti-Bacterial Agents | Major topic |
| Drug Resistance, Bacterial | Major topic |
| Escherichia coli Proteins | |
| Microbial Sensitivity Tests |
Source PubMed
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38666213 | Scalable and efficient DNA sequencing analysis on different compute infrastructures aiding variant discovery. | NAR Genom Bioinform | 2024 | https://conductscience.org/library/papers/38666213 | PubMed |
| 2 | 31626749 | Bacterial Heterogeneity and Antibiotic Survival: Understanding and Combatting Persistence and Heteroresistance. | Mol Cell | 2019 | https://conductscience.org/library/papers/31626749 | PubMed |
| 3 | 26960938 | Fosfomycin. | Clin Microbiol Rev | 2016 | https://conductscience.org/library/papers/26960938 | PubMed |
| 4 | 39748127 | Metabolic mutations reduce antibiotic susceptibility of E. coli by pathway-specific bottlenecks. | Mol Syst Biol | 2025 | https://conductscience.org/library/papers/39748127 | PubMed |
| 5 | 28197413 | Mechanism of Reduced Susceptibility to Fosfomycin in Escherichia coli Clinical Isolates. | Biomed Res Int | 2017 | https://conductscience.org/library/papers/28197413 | PubMed |
| 6 | 33238135 | Multi-omics Analysis of CRISPRi-Knockdowns Identifies Mechanisms that Buffer Decreases of Enzymes in E. coli Metabolism. | Cell Syst | 2021 | https://conductscience.org/library/papers/33238135 | PubMed |
| 7 | 36646716 | Deep mutational scanning of essential bacterial proteins can guide antibiotic development. | Nat Commun | 2023 | https://conductscience.org/library/papers/36646716 | PubMed |
| 8 | 32756955 | A genome-wide analysis of Escherichia coli responses to fosfomycin using TraDIS-Xpress reveals novel roles for phosphonate degradation and phosphate transport systems. | J Antimicrob Chemother | 2020 | https://conductscience.org/library/papers/32756955 | PubMed |
| 9 | 29042431 | In situ genotyping of a pooled strain library after characterizing complex phenotypes. | Mol Syst Biol | 2017 | https://conductscience.org/library/papers/29042431 | PubMed |
| 10 | 30013048 | Strelka2: fast and accurate calling of germline and somatic variants. | Nat Methods | 2018 | https://conductscience.org/library/papers/30013048 | PubMed |
| 11 | 23071270 | SortMeRNA: fast and accurate filtering of ribosomal RNAs in metatranscriptomic data. | Bioinformatics | 2012 | https://conductscience.org/library/papers/23071270 | PubMed |
| 12 | 37666266 | High prevalence and global distribution of fosfomycin resistance genes in Salmonella serovars. | Lancet Microbe | 2023 | https://conductscience.org/library/papers/37666266 | PubMed |
| 13 | 35163052 | Fosfomycin Resistance Evolutionary Pathways of Stenotrophomonas maltophilia in Different Growing Conditions. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35163052 | PubMed |
| 14 | 8664284 | Characterization of a Cys115 to Asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin. | Biochemistry | 1996 | https://conductscience.org/library/papers/8664284 | PubMed |
| 15 | 31279676 | Bacterial Metabolism and Antibiotic Efficacy. | Cell Metab | 2019 | https://conductscience.org/library/papers/31279676 | PubMed |
| 16 | 33274447 | Understanding tolerance to cell wall-active antibiotics. | Ann N Y Acad Sci | 2021 | https://conductscience.org/library/papers/33274447 | PubMed |
| 17 | 20515462 | Revealing fosfomycin primary effect on Staphylococcus aureus transcriptome: modulation of cell envelope biosynthesis and phosphoenolpyruvate induced starvation. | BMC Microbiol | 2010 | https://conductscience.org/library/papers/20515462 | PubMed |
| 18 | 32055031 | The nf-core framework for community-curated bioinformatics pipelines. | Nat Biotechnol | 2020 | https://conductscience.org/library/papers/32055031 | PubMed |
| 19 | 31235888 | Mechanisms and clinical relevance of bacterial heteroresistance. | Nat Rev Microbiol | 2019 | https://conductscience.org/library/papers/31235888 | PubMed |
| 20 | 30423086 | fastp: an ultra-fast all-in-one FASTQ preprocessor. | Bioinformatics | 2018 | https://conductscience.org/library/papers/30423086 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41665249
GET https://conductscience.org/api/papers/v1/41665249/references?page=2